Corporate Overview
Amronco
Lifesciences Ltd. is not merely a corporate entity but an effort towards
fighting cancer and disease. This dream was conceptualized by Mr. Y. R.
Mohan Rao in 1979 along with a group of ten eminent Indian doctors with the
inception of our parent company MacMohan Pharma Ltd. Today, his dream has
matured into a reality with a corporate office and plant at Hyderabad and
services spread across a number of countries.
Our effort has been to specialize in the manufacture of niché
products, focused mainly in the field of Oncology – an ailment still
costing lives of our precious ones in huge numbers. There has been much
research going on in this field but we still need alternative medicines that
can help save more lives.
Our key areas of research are focused in the field of chemotherapy, biotech
recombinant products & developing novel drug delivery systems.
For a consistent and sustained growth, we find it very important to have an
organizational structure where not only processes are well defined, but
responsibilities are also clearly assigned. This focus exhibits character of
our organization that is far-sighted, self-sufficing and has outlined a
sharp progress plan for future.
We are committed to helping people and communities to improve their health.
We have two approaches for this purpose. Firstly, we are in a process of
developing new medicines to assist people deal with their health matters a
lot more efficiently. Secondly, we keep in touch with healthcare providers
and talk to them about the medicines they use and the medical conditions
they treat. This helps in making the process more feedback oriented and
customer driven.
Our aim is not only to innovate and develop medicines but also to make them
available to people at reasonable cost so that everyone can avail healthcare
facilities, anywhere across the globe.
Products
We are engaged in manufacturing and supplying medicines such as :
Quality
& Certifications
We adhere to the international guidelines set by the World Health
Organization for pharmaceutical companies throughout the world. There is a
regular upgradation of the facilities at our manufacturing unit to keep up
with stringent safety regulations not just for business interests but more
so because we care for our employees and any lapse on the quality part does
not abide with our company ethics.
Features
Amronco Aid Foundation (AAF)
Amronco Aid Foundation is set up with the idea of providing products free
to the poor and needy children in the society towards fulfilling our social
obligations.
Accreditations
Our New manufacturing Unit
Plot No. P5 & P6
Green Industrial Park
Jadcharla N.H. - 7
Near International Airport |
Amronco – US FDA Facility :
Amronco – US FDA compliant facility for
manufacture of cytotoxic & non-cytotoxic biotech formulations in
Injectables & Orals is coming up at Green Industrial Park, Jadcherla,
where we have recently acquired 10 acres of land from the state government.
This facility will house state of the art containment protocols for
manufacture of cytotoxic products and other critical care products.
The biotech formulation facility will house state of the art R&D
facilities & infrastructure for cell culture, expression, purification
etc.
The manufacturing ALL facility is being built in about 100,000sft at Green
Industrial Park, Jadcherla in close vicinity to Hyderabad International
Airport.
The plant will commence production from Jan. 2010 & obtain FDA
permission by Dec 2010.
RAINSTORM LABS :
Rainstorm labs was incorporated in 2007 to ensure consistency in the
quality of api's Used in our formulations.
Rainstorm labs develops Non-infringing patent technologies for each api
developed through a committed inhouse R&D team.
We are in the process of setting up a state of art facility for the
manufacture of API's using custom synthesis with capacities ranging from
kilo lab to bulk commercial scale batches.
